Black Bird Biotech, Inc.
Black Bird Biotech, Inc. (BBBT) SEC Filings & 10-K Annual Reports
SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.
SEC EDGAR · data.sec.gov · CIK 0001409999 · BBBT · OTC · as of Jun 9, 2026
Filing snapshot
Source: SEC EDGAR (data.sec.gov) · CIK 0001409999 · Updated hourly · Not investment advice
Latest Annual Report
Latest Key Filings
Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.
SEC Filing History
About SEC Filings & 10-K Annual Reports
Black Bird Biotech, Inc. (OTC: BBBT) has submitted 214 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2009. As a Healthcare sector company with CIK 0001409999, all filings are publicly accessible via the EDGAR database at no cost.
The annual 10-K report is Black Bird Biotech, Inc.'s most comprehensive regulatory disclosure. The most recent Black Bird Biotech, Inc. 10-K was filed on 2023-03-21 for fiscal year ending 2023. Historical BBBT 10-K annual reports are available from 2007 through 2023.
Investors researching Black Bird Biotech, Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.
Frequently Asked Questions
BBBT SEC Filings · 8 questionsBlack Bird Biotech, Inc. (BBBT) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 214 filings and access original documents at no cost. Black Bird Biotech, Inc.'s CIK is 0001409999.